Diabetic Microvascular Complications News

• Alert FDA Clears Spinal Cord Stimulator for Diabetic Neuropathy The Food and Drug Administration has approved Abbott's Proclaim XR spinal cord stimulation system for the treatment of diabetic peripheral neuropathy, the company announced.
  Medscape Medical News, January 26, 2023
• Eye Check Important Before Starting Semaglutide for Diabetes Meta-analysis finds small increased risk of retinopathy worsening after starting injectable semaglutide.
  Medscape Medical News, January 24, 2023
• AI Takes Root in Primary Care. First Stop: Diabetic Retinopathy Within seconds, artificial intelligence algorithms are diagnosing a complication of diabetes that can lead to blindness.
  Medscape Medical News, December 15, 2022
• Risks From Latent Autoimmune Diabetes in Adults Resemble Those for T2D The mortality and cardiovascular disease risks of people with latent autoimmune diabetes in adults was similar, but retinopathy risk higher, than those with type 2 diabetes in a Swedish study.
  First Look, December 14, 2022
• Treatment Type Doesn't Affect Risk of Retinal Detachment in DR Giving intravitreal injection only, or laser only, makes no difference to risk of later retinal detachment in patients with proliferative diabetic retinopathy, nor does 6-months plus loss to follow-up.
  Medscape Medical News, December 07, 2022
• AEYE Health Gets FDA Approval to Screen Diabetics to Prevent Blindness Israeli digital health firm AEYE Health said on Tuesday it received clearance from the FDA to market its screening system to detect damage to the retina of the eyes in diabetics.
  Reuters Health Information, November 15, 2022
• UEG 2022 Type 1 Diabetes Complications Tied to Gut Microbiome Changes Alterations to composition and function of the gut microbiome have been identified in people with type 1 diabetes complications, with the greatest changes found in those with diabetic nephropathy.
  Medscape Medical News, October 09, 2022
• AAO 2022 With Approval Pending, Pegcetacoplan Phase 3 Results Mixed With an FDA action date set, investigative complement inhibitor pegcetacoplan showed a signal for improving visual function in geographic atrophy but also a risk for conversion to wet AMD.
  Medscape Medical News, October 03, 2022
• EASD 2022 Another Study Shows Fenofibrate Benefit on Diabetic Retinopathy While a Korean study shows reduction in diabetic retinopathy progression by 11% with fenofibrate plus statin compared with statin alone, some reservations remain over wider use.
  Medscape Medical News, September 23, 2022
• Type 1 Diabetes Complication Risk Rises With A1c, Duration Study following people for over 30 years from the time of type 1 diabetes diagnosis finds increasing risk of complications with A1c levels above a certain threshold, increasing duration of disease.
  Medscape Medical News, September 22, 2022
• EASD 2022 'Amazing' Data for Cheap Beta-Blocker Gel for Diabetic Foot Ulcers Esmolol, a widely available and cheap beta-blocker, shows statistically significant superiority over the standard of care for diabetic foot ulcers, according to new, 'potentially game-changing' phase 3 data.
  Medscape Medical News, September 21, 2022
• EASD 2022 Stockholm Calls: Docs Eye New Tactics for Type 2 Diabetes at EASD New data on tirzepatide for weight loss and potential type 2 diabetes remission as well as an update on use of dapagliflozin for heart failure will be presented at the first in-person EASD meeting for 3 years.
  Medscape Medical News, September 14, 2022
• Residential Greenness May Protect Against Diabetic Retinopathy Findings point to importance of promoting greenness exposure.
  First Look, August 12, 2022
• Neuropathy Drives Hypoglycemia Cluelessness in T1D People with type 1 diabetes may be unaware of hypoglycemia episodes because of peripheral neuropathy, while insulin pump use and higher problem-solving perception each linked with improved awareness.
  First Look, August 01, 2022
• ASRS 2022 Methotrexate Could Reduce the Risk for Retinal Redetachment Intravitreal injections with methotrexate appear to reduce scar formation after retinal reattachment even in patients with proliferative diabetic retinopathy.
  Medscape Medical News, July 20, 2022
• ASRS 2022 Gene Therapy Looks Promising for Diabetic Retinopathy Genes engineered to make an antivascular endothelial growth factor drug showed encouraging results in a phase 2 trial.
  Medscape Medical News, July 19, 2022
• ASRS 2022 Metformin Shows Potential to Prevent Macular Degeneration People prescribed the diabetes drug metformin may be less likely to develop age-related macular degeneration.
  Medscape Medical News, July 18, 2022
• ASRS 2022 Infrared Imaging Explored for Diabetic Retinopathy Screening Infrared reflectance imaging could provide an opportunity to screen more patients for diabetic retinopathy.
  Medscape Medical News, July 15, 2022
• Bevacizumab First Matches Aflibercept for Diabetic Macular Edema Results from a randomized trial showed that step therapy for diabetic macular edema with lower-priced bevacizumab followed by pricier aflibercept, when needed, works as well as aflibercept monotherapy.
  Medscape Medical News, July 14, 2022
• Diabetic Neuropathy Associated With Chewing Difficulty Patients with diabetic neuropathy may have difficulty chewing, which may interfere with their ability to follow nutrition advice for optimal blood glucose control, a small study in Japan suggests.
  Medscape Medical News, June 30, 2022